BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Su YW, Chen X, Jiang ZZ, Wang T, Wang C, Zhang Y, Wen J, Xue M, Zhu D, Zhang Y, Su YJ, Xing TY, Zhang CY, Zhang LY. A panel of serum microRNAs as specific biomarkers for diagnosis of compound- and herb-induced liver injury in rats. PLoS One 2012;7:e37395. [PMID: 22624025 DOI: 10.1371/journal.pone.0037395] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Thulin P, Nordahl G, Gry M, Yimer G, Aklillu E, Makonnen E, Aderaye G, Lindquist L, Mattsson CM, Ekblom B, Antoine DJ, Park BK, Linder S, Harrill AH, Watkins PB, Glinghammar B, Schuppe-Koistinen I. Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts.Liver Int. 2014;34:367-378. [PMID: 24118944 DOI: 10.1111/liv.12322] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 8.0] [Reference Citation Analysis]
2 Li XJ, Jiang ZZ, Zhang LY. Triptolide: progress on research in pharmacodynamics and toxicology. J Ethnopharmacol. 2014;155:67-79. [PMID: 24933225 DOI: 10.1016/j.jep.2014.06.006] [Cited by in Crossref: 183] [Cited by in F6Publishing: 186] [Article Influence: 26.1] [Reference Citation Analysis]
3 Koutsoulidou A, Kyriakides TC, Papadimas GK, Christou Y, Kararizou E, Papanicolaou EZ, Phylactou LA. Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress. PLoS One 2015;10:e0125341. [PMID: 25915631 DOI: 10.1371/journal.pone.0125341] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 5.5] [Reference Citation Analysis]
4 Krauskopf J, Verheijen M, Kleinjans JC, de Kok TM, Caiment F. Development and regulatory application of microRNA biomarkers. Biomark Med 2015;9:1137-51. [PMID: 26502281 DOI: 10.2217/bmm.15.50] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
5 Falcon-perez JM, Royo F. Circulating RNA: looking at the liver through a frosted glass. Biomarkers 2015;20:339-54. [DOI: 10.3109/1354750x.2015.1101785] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
6 Zhong Y, Pei Y, Wang J, Chen J, Jiang S, Gong J. MicroRNA expression profile in myocardial bridging patients. Scandinavian Journal of Clinical and Laboratory Investigation 2014;74:582-7. [DOI: 10.3109/00365513.2014.921324] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
7 Teschke R, Schulze J, Eickhoff A, Danan G. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment? Int J Mol Sci. 2017;18:E803. [PMID: 28398242 DOI: 10.3390/ijms18040803] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
8 Rodrigues D, Monteiro M, Jerónimo C, Henrique R, Belo L, Bastos ML, Guedes de Pinho P, Carvalho M. Renal cell carcinoma: a critical analysis of metabolomic biomarkers emerging from current model systems. Transl Res 2017;180:1-11. [PMID: 27546593 DOI: 10.1016/j.trsl.2016.07.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
9 Krauskopf J, Kleinjans JC, de Kok TM. Circulating MicroRNAs as Novel Biomarkers of Drug-Induced Liver Injury in Humans. In: Chen M, Will Y, editors. Drug-Induced Liver Toxicity. New York: Springer; 2018. pp. 597-610. [DOI: 10.1007/978-1-4939-7677-5_28] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yu HW, Cho WC. The role of microRNAs in toxicology. Arch Toxicol 2015;89:319-25. [DOI: 10.1007/s00204-014-1440-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
11 Ji C, Zheng J, Tong W, Lu X, Fan X, Gao Y. Revealing the mechanism of Fructus meliae toosendan -induced liver injury in mice by integrating microRNA and mRNA-based toxicogenomics data. RSC Adv 2015;5:81774-83. [DOI: 10.1039/c5ra10112c] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Zhao DS, Jiang LL, Fan YX, Wang LL, Li ZQ, Shi W, Li P, Li HJ. Investigation of Dioscorea bulbifera Rhizome-Induced Hepatotoxicity in Rats by a Multisample Integrated Metabolomics Approach. Chem Res Toxicol 2017;30:1865-73. [PMID: 28899093 DOI: 10.1021/acs.chemrestox.7b00176] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
13 Koturbash I, Tolleson WH, Guo L, Yu D, Chen S, Hong H, Mattes W, Ning B. microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment. Biomark Med 2015;9:1153-76. [PMID: 26501795 DOI: 10.2217/bmm.15.89] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 7.5] [Reference Citation Analysis]
14 Akbari G, Mard SA, Dianat M, Mansouri E. The Hepatoprotective and MicroRNAs Downregulatory Effects of Crocin Following Hepatic Ischemia-Reperfusion Injury in Rats. Oxid Med Cell Longev 2017;2017:1702967. [PMID: 28367266 DOI: 10.1155/2017/1702967] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
15 Wang LL, Zhao DS, Shi W, Li ZQ, Wu ZT, Li P, Li HJ. Describing the holistic toxicokinetics of hepatotoxic Chinese herbal medicines by a novel integrated strategy: Dioscorea bulbifera rhizome as a case study. J Chromatogr B Analyt Technol Biomed Life Sci 2017;1064:40-8. [PMID: 28910661 DOI: 10.1016/j.jchromb.2017.08.040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
16 McGill MR, Jaeschke H. Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients. Expert Opin Drug Metab Toxicol 2014;10:1005-17. [PMID: 24836926 DOI: 10.1517/17425255.2014.920823] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 10.4] [Reference Citation Analysis]
17 Florczyk M, Brzuzan P, Krom J, Woźny M, Łakomiak A. miR-122-5p as a plasma biomarker of liver injury in fish exposed to microcystin-LR. J Fish Dis 2016;39:741-51. [PMID: 26345281 DOI: 10.1111/jfd.12406] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
18 Gould BR, Damgaard T, Nielsen BS. Chromogenic In Situ Hybridization Methods for microRNA Biomarker Monitoring of Drug Safety and Efficacy. Methods Mol Biol 2017;1641:399-412. [PMID: 28748477 DOI: 10.1007/978-1-4939-7172-5_22] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
19 Ogata K, Sumida K, Miyata K, Kushida M, Kuwamura M, Yamate J. Circulating miR-9* and miR-384-5p as potential indicators for trimethyltin-induced neurotoxicity. Toxicol Pathol 2015;43:198-208. [PMID: 24777749 DOI: 10.1177/0192623314530533] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
20 Marrone AK, Beland FA, Pogribny IP. The role for microRNAs in drug toxicity and in safety assessment. Expert Opin Drug Metab Toxicol 2015;11:601-11. [PMID: 25739314 DOI: 10.1517/17425255.2015.1021687] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
21 Zheng J, Ji C, Lu X, Tong W, Fan X, Gao Y. Integrated expression profiles of mRNA and microRNA in the liver of Fructus Meliae Toosendan water extract injured mice. Front Pharmacol 2015;6:236. [PMID: 26539117 DOI: 10.3389/fphar.2015.00236] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
22 Gehrau RC, Mas VR, Maluf DG. Hepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs? Expert Rev Gastroenterol Hepatol. 2013;7:157-170. [PMID: 23363264 DOI: 10.1586/egh.12.71] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
23 Etheridge A, Gomes CP, Pereira RW, Galas D, Wang K. The complexity, function and applications of RNA in circulation. Front Genet 2013;4:115. [PMID: 23785385 DOI: 10.3389/fgene.2013.00115] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
24 Amacher DE, Schomaker SJ, Aubrecht J. Development of blood biomarkers for drug-induced liver injury: an evaluation of their potential for risk assessment and diagnostics. Mol Diagn Ther 2013;17:343-54. [PMID: 23868512 DOI: 10.1007/s40291-013-0049-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
25 Ma J, Li X. MicroRNAs are involved in the toxicity of microcystins. Toxin Reviews 2016;36:165-75. [DOI: 10.1080/15569543.2016.1258713] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
26 Mard SA, Akbari G, Dianat M, Mansouri E. The Effect of Zinc Sulfate on miR-122, miR-34a, Atioxidants, Biochemical and Histopathological Parameters Following Hepatic Ischemia/Reperfusion Injury in Rats. Biol Trace Elem Res 2019;188:434-40. [PMID: 30014282 DOI: 10.1007/s12011-018-1425-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
27 Yu YC, Mao YM, Chen CW, Chen JJ, Chen J, Cong WM, Ding Y, Duan ZP, Fu QC, Guo XY, Hu P, Hu XQ, Jia JD, Lai RT, Li DL, Liu YX, Lu LG, Ma SW, Ma X, Nan YM, Ren H, Shen T, Wang H, Wang JY, Wang TL, Wang XJ, Wei L, Xie Q, Xie W, Yang CQ, Yang DL, Yu YY, Zeng MD, Zhang L, Zhao XY, Zhuang H;  Drug-induced Liver Injury (DILI) Study Group;  Chinese Society of Hepatology (CSH);  Chinese Medical Association (CMA). CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol Int. 2017;11:221-241. [PMID: 28405790 DOI: 10.1007/s12072-017-9793-2] [Cited by in Crossref: 92] [Cited by in F6Publishing: 87] [Article Influence: 23.0] [Reference Citation Analysis]
28 McGill MR, Jaeschke H. MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury. J Clin Med. 2015;4:1063-1078. [PMID: 26167291 DOI: 10.3390/jcm4051063] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
29 Wolenski FS, Shah P, Sano T, Shinozawa T, Bernard H, Gallacher MJ, Wyllie SD, Varrone G, Cicia LA, Carsillo ME, Fisher CD, Ottinger SE, Koenig E, Kirby PJ. Identification of microRNA biomarker candidates in urine and plasma from rats with kidney or liver damage. J Appl Toxicol 2017;37:278-86. [PMID: 27397436 DOI: 10.1002/jat.3358] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
30 Lin H, Ewing LE, Koturbash I, Gurley BJ, Miousse IR. MicroRNAs as biomarkers for liver injury: Current knowledge, challenges and future prospects. Food Chem Toxicol 2017;110:229-39. [PMID: 29042291 DOI: 10.1016/j.fct.2017.10.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
31 Teschke R. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.Expert Opin Drug Metab Toxicol. 2018;14:1169-1187. [PMID: 30354694 DOI: 10.1080/17425255.2018.1539077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
32 Beger RD, Bhattacharyya S, Yang X, Gill PS, Schnackenberg LK, Sun J, James LP. Translational biomarkers of acetaminophen-induced acute liver injury. Arch Toxicol 2015;89:1497-522. [PMID: 25983262 DOI: 10.1007/s00204-015-1519-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
33 Carreiro S, Marvel-Coen J, Lee R, Chapman B, Ambros V. Circulating microRNA Profiles in Acetaminophen Toxicity. J Med Toxicol 2020;16:177-87. [PMID: 31792846 DOI: 10.1007/s13181-019-00739-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Loiodice S, Nogueira da Costa A, Atienzar F. Current trends in in silico , in vitro toxicology, and safety biomarkers in early drug development. Drug and Chemical Toxicology 2019;42:113-21. [DOI: 10.1080/01480545.2017.1400044] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
35 Hwang SR, Tham NTT, Lee SH, Bang JH, Yi H, Park YI, Lee HK, Kang HG, Kim YS, Woo GH, Ku HO. Comparison of microRNA expressions for the identification of chemical hazards in in vivo and in vitro hepatic injury models. J Appl Toxicol 2019;39:333-42. [PMID: 30264499 DOI: 10.1002/jat.3722] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
36 Wang W, Shi Q, Mattes WB, Mendrick DL, Yang X. Translating extracellular microRNA into clinical biomarkers for drug-induced toxicity: from high-throughput profiling to validation. Biomark Med 2015;9:1177-88. [PMID: 26501984 DOI: 10.2217/bmm.15.86] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
37 Schueller F, Roy S, Vucur M, Trautwein C, Luedde T, Roderburg C. The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity. Int J Mol Sci. 2018;19:pii: E261. [PMID: 29337905 DOI: 10.3390/ijms19010261] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 17.3] [Reference Citation Analysis]
38 Wang Y, Chen T, Tong W. miRNAs and their application in drug-induced liver injury. Biomark Med. 2014;8:161-172. [PMID: 24521012 DOI: 10.2217/bmm.13.147] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
39 Shi Q, Yang X, Mendrick DL. Hopes and challenges in using miRNAs as translational biomarkers for drug-induced liver injury. Biomark Med. 2013;7:307-315. [PMID: 23547824 DOI: 10.2217/bmm.13.9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
40 Vliegenthart AD, Antoine DJ, Dear JW. Target biomarker profile for the clinical management of paracetamol overdose. Br J Clin Pharmacol 2015;80:351-62. [PMID: 26076366 DOI: 10.1111/bcp.12699] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
41 Teschke R, Larrey D, Melchart D, Danan G. Traditional Chinese Medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs. Medicines. 2016;3:18. [PMID: 28930128 DOI: 10.3390/medicines3030018] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 9.6] [Reference Citation Analysis]
42 Niu C, Sheng Y, Yang R, Lu B, Bai Q, Ji L, Wang Z. Scutellarin protects against the liver injury induced by diosbulbin B in mice and its mechanism. J Ethnopharmacol. 2015;164:301-308. [PMID: 25701748 DOI: 10.1016/j.jep.2015.02.031] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
43 Zhang CE, Niu M, Li Q, Zhao YL, Ma ZJ, Xiong Y, Dong XP, Li RY, Feng WW, Dong Q, Ma X, Zhu Y, Zou ZS, Cao JL, Wang JB, Xiao XH. Urine metabolomics study on the liver injury in rats induced by raw and processed Polygonum multiflorum integrated with pattern recognition and pathways analysis. J Ethnopharmacol 2016;194:299-306. [PMID: 27620661 DOI: 10.1016/j.jep.2016.09.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
44 Mard SA, Akbari G, Dianat M, Mansouri E. Protective effects of crocin and zinc sulfate on hepatic ischemia-reperfusion injury in rats: a comparative experimental model study. Biomed Pharmacother 2017;96:48-55. [PMID: 28963950 DOI: 10.1016/j.biopha.2017.09.123] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
45 Li LM, Wang D, Zen K. MicroRNAs in Drug-induced Liver Injury. J Clin Transl Hepatol. 2014;2:162-169. [PMID: 26357624 DOI: 10.14218/jcth.2014.00015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
46 Chu Y, Ouyang Y, Wang F, Zheng A, Bai L, Han L, Chen Y, Wang H. MicroRNA-590 promotes cervical cancer cell growth and invasion by targeting CHL1. J Cell Biochem 2014;115:847-53. [PMID: 24288179 DOI: 10.1002/jcb.24726] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 8.4] [Reference Citation Analysis]
47 Vincent R, Sanyal A. Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players. Curr Pathobiol Rep 2014;2:109-15. [PMID: 25574453 DOI: 10.1007/s40139-014-0049-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
48 Motawi TK, Mohamed MR, Shahin NN, Ali MA, Azzam MA. Time-course expression profile and diagnostic potential of a miRNA panel in exosomes and total serum in acute liver injury. The International Journal of Biochemistry & Cell Biology 2018;100:11-21. [DOI: 10.1016/j.biocel.2018.05.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
49 Vliegenthart AD, Shaffer JM, Clarke JI, Peeters LE, Caporali A, Bateman DN, Wood DM, Dargan PI, Craig DG, Moore JK, Thompson AI, Henderson NC, Webb DJ, Sharkey J, Antoine DJ, Park BK, Bailey MA, Lader E, Simpson KJ, Dear JW. Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury. Sci Rep 2015;5:15501. [PMID: 26489516 DOI: 10.1038/srep15501] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 13.8] [Reference Citation Analysis]
50 Eguchi A, Wree A, Feldstein AE. Biomarkers of liver cell death. J Hepatol. 2014;60:1063-1074. [PMID: 24412608 DOI: 10.1016/j.jhep.2013.12.026] [Cited by in Crossref: 109] [Cited by in F6Publishing: 106] [Article Influence: 15.6] [Reference Citation Analysis]
51 Vu LT, Gong J, Pham TT, Kim Y, Le MTN. microRNA exchange via extracellular vesicles in cancer. Cell Prolif 2020;53:e12877. [PMID: 33169503 DOI: 10.1111/cpr.12877] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]